<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20120527009878N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-03</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of surgical methods in the treatment of cerebral arteries aneurysms</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of surgical clipping and interventional coiling in the progressive anterior circulation aneurysms of brain.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-08-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/33277</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: First, patients will be listed by file number. Then, by using the rand command in Microsoft EXCEL 2007 software, for each patients, a code between 1 and 120 will be assigned. To divide the patients into the first and second intervention groups, using the code given to the patients, the patients with the odd code will be assigned to the first intervention group and the patients with the even code will be assigned into the second intervention group, Blinding description: In this study, clinical caregivers (operating room personnel), outcome elevators (operating room and neurosurgery ward nurses), and data analyzers will be blind to the profile of patients. Blindness will be done by removing the name and surname and other information that will allow access to patient profiles. Patients will be encoded, and this coding is obvious just to the researcher.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cerebral anterior circular aneurysm.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In coiling intervention, composite springs are used to fill the aneurysm and remove it from the main circulation system. In this method, the neurosurgeon initially slices in the arterial arm or leg of the patient, and then sends the catheter to the brain and to the vascular aneurysm. The neurosurgeon then inserts a soft wire spring into the vascular aneurysm. This spring corrects blood flow and forms a blood clot that acts as a vascular aneurysm cushion and prevents it from bursting. Intervention 2: Intervention group 2: In this method, coiling is done with clipping. Composite springs are used to fill the aneurysm and remove it from the main circulation system. In this method, the neurosurgeon initially slices in the arterial arm or leg of the patient, and then sends the catheter to the brain and to the vascular aneurysm. The neurosurgeon then inserts a soft wire spring into the vascular aneurysm. This spring corrects blood flow and forms a blood clot that acts as a vascular aneurysm cushion and prevents it from bursting. Clips are then used to restrict the artery wall to perform Clipping.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
A portion of the data that represents the final outcome

When:
Available after publication.

To whom:
All Physicians and residents of the neurosurgery department

Conditions:
After obtaining permission from the neurosurgery department

Where to obtain:
Person who responsible for scientific accountability of study.

How to obtain:
After approval of the research vice-president.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Firoz Salehpoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Neurosurgery ward, Emam Reza Hospital, Gholghasht Street, Azadi Street, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614756</zip>
        <telephone>+98 41 1334 0830</telephone>
        <email>salehpourf@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Firoz Salehpoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Neurosurgery ward, Emam Reza Hospital, Gholghasht Street, Azadi Street, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614756</zip>
        <telephone>+98 41 3334 7054</telephone>
        <email>salehpourf@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Glasgow coma scale (GCS) equal or greater than 9
Non-giant aneurysms of less than 10 mm in size
Anterior circular aneurysms of the brain</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Glasgow coma scale (GCS) less than 8
Giant's aneurysms larger than 10 mm
Desiccant aneurysms</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I67.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral aneurysm, nonruptured</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In coiling intervention, composite springs are used to fill the aneurysm and remove it from the main circulation system. In this method, the neurosurgeon initially slices in the arterial arm or leg of the patient, and then sends the catheter to the brain and to the vascular aneurysm. The neurosurgeon then inserts a soft wire spring into the vascular aneurysm. This spring corrects blood flow and forms a blood clot that acts as a vascular aneurysm cushion and prevents it from bursting.</i_keyword>
      <i_keyword>Intervention group 2: In this method, coiling is done with clipping. Composite springs are used to fill the aneurysm and remove it from the main circulation system. In this method, the neurosurgeon initially slices in the arterial arm or leg of the patient, and then sends the catheter to the brain and to the vascular aneurysm. The neurosurgeon then inserts a soft wire spring into the vascular aneurysm. This spring corrects blood flow and forms a blood clot that acts as a vascular aneurysm cushion and prevents it from bursting. Clips are then used to restrict the artery wall to perform Clipping.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Post-operative mortality rate. Timepoint: Two weeks after intervention. Method of measurement: Questionnaire on postoperative complications.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Post-surgical complications frequency. Timepoint: Intervention day, Four weeks after intervention. Method of measurement: Questionnaire on postoperative complications.</sec_outcome>
      <sec_outcome>Re-bleeding frequency. Timepoint: Intervention day, Four weeks after intervention. Method of measurement: Questionnaire on postoperative complications.</sec_outcome>
      <sec_outcome>Aneurysm wall improvement frequency. Timepoint: Intervention day, Four weeks after intervention. Method of measurement: Questionnaire on postoperative complications.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-08-06</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Central Building No. 2, Tabriz University of Medical Sciences, Golghast St Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
